These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29070940)

  • 1. Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment.
    Janssen EM; Longo DR; Bardsley JK; Bridges JF
    Patient Prefer Adherence; 2017; 11():1729-1736. PubMed ID: 29070940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Huang Y; Huang Q; Xu A; Lu M; Xi X
    Front Public Health; 2021; 9():782964. PubMed ID: 35178370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
    Janssen EM; Hauber AB; Bridges JFP
    Value Health; 2018 Jan; 21(1):59-68. PubMed ID: 29304942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Chuang LH; Zhang H; Hong T; Xie S
    Patient; 2024 Sep; 17(5):565-574. PubMed ID: 38642244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.
    Hauber AB; Han S; Yang JC; Gantz I; Tunceli K; Gonzalez JM; Brodovicz K; Alexander CM; Davies M; Iglay K; Zhang Q; Radican L
    Patient Prefer Adherence; 2013; 7():937-49. PubMed ID: 24086104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.
    Lloyd A; McIntosh E; Price M
    Pharmacoeconomics; 2005; 23(11):1167-81. PubMed ID: 16277551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing the delivery of dental care: Heterogeneity in patients' preferences and willingness-to-pay for dental care attributes.
    Sever I; Verbič M; Sever EK
    J Dent; 2018 Feb; 69():93-101. PubMed ID: 29242040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does patients' quality of life guide their preferences regarding aspects of asthma therapy?: a patient-preference study using discrete-choice experiment methodology.
    Lloyd A; McIntosh E; Williams AE; Kaptein A; Rabe KF
    Patient; 2008 Dec; 1(4):309-16. PubMed ID: 22272998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.
    Johnson P; Bancroft T; Barron R; Legg J; Li X; Watson H; Naeim A; Watkins A; Marshall DA
    Value Health; 2014 Jun; 17(4):380-9. PubMed ID: 24968998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
    Marshall HS; Chen G; Clarke M; Ratcliffe J
    Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
    Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
    Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and choice in health insurance: evidence from a discrete choice experiment.
    Becker K; Zweifel P
    Patient; 2008 Jan; 1(1):27-40. PubMed ID: 22272755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for flexibility at the workplace for people with diabetes and chronic disease: a discrete choice experiment in a population of workers in Denmark.
    Madsen KP; Cleal B; Olesen K; Hagelund L; Willaing I
    BMC Public Health; 2019 May; 19(1):584. PubMed ID: 31096952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment.
    Lv Y; Ren R; Tang C; Song K; Li S; Wang H
    Patient Prefer Adherence; 2022; 16():2335-2344. PubMed ID: 36046499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for flexible working conditions of people with type 2 diabetes: discrete choice experiments.
    Nexo MA; Cleal B; Hagelund L; Willaing I; Olesen K
    BMC Public Health; 2017 Dec; 17(1):938. PubMed ID: 29241444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.